We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
+$224M
Cap. Flow %
177.31%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$3.82M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.47M
3
IBB icon
iShares Biotechnology ETF
IBB
+$2M
4
ULTA icon
Ulta Beauty
ULTA
+$1.86M
5
MON
Monsanto Co
MON
+$1.82M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
2
BIIB icon
Biogen
BIIB
+$4.33M
3
CALM icon
Cal-Maine
CALM
+$3.64M
4
AAPL icon
Apple
AAPL
+$2.74M
5
ALR
Alere Inc
ALR
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 39.95%
2 Consumer Staples 5.72%
3 Consumer Discretionary 5.14%
4 Technology 3.35%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTR icon
301
PUT
Nektar Therapeutics
NKTR
$2.31B
$10K 0.01%
+333
New +$85.7K
TNXP icon
302
Tonix Pharmaceuticals
TNXP
$198M
– –
0
– –
WMT icon
303
CALL
Walmart Inc
WMT
$909B
$10K 0.01%
90,000
-195,000
-68% -$4.73M
AIG icon
304
PUT
American International
AIG
$42.7B
$9K 0.01%
+12,500
New +$714K
ASRT
305
PUT
DELISTED
Assertio
ASRT
$9K 0.01%
+250
New +$314K
CHD icon
306
CALL
Church & Dwight Co
CHD
$23.2B
$9K 0.01%
37,200
+1,600
+4% +$79K
NKE icon
307
PUT
Nike
NKE
$64.9B
$9K 0.01%
+5,000
New +$282K
PBYI icon
308
CALL
Puma Biotechnology
PBYI
$434M
$9K 0.01%
+12,500
New +$632K
SO icon
309
CALL
Southern Company
SO
$107B
$9K 0.01%
100,000
-114,000
-53% -$6M
T icon
310
CALL
AT&T
T
$152B
$9K 0.01%
51,106
-127,634
-71% -$4.03M
AKBA icon
311
CALL
Akebia Therapeutics
AKBA
$359M
$8K 0.01%
35,000
– –
CRM icon
312
CALL
Salesforce
CRM
$140B
$8K 0.01%
3,800
-8,700
-70% -$679K
ORCL icon
313
CALL
Oracle
ORCL
$364B
$8K 0.01%
20,200
+200
+1% +$8.15K
RPTP
314
PUT
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$8K 0.01%
87,700
+79,300
+944% +$564K
DVAX
315
CALL
DELISTED
Dynavax Technologies
DVAX
$7K 0.01%
+34,000
New +$489K
HD icon
316
CALL
Home Depot
HD
$338B
$7K 0.01%
15,000
– –
LUMN icon
317
PUT
Lumen
LUMN
$6.47B
$7K 0.01%
12,800
– –
MNDT
318
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
$7K 0.01%
13,000
-5,000
-28% -$76.8K
POT
319
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
$7K 0.01%
10,000
-10,000
-50% -$165K
DD
320
PUT
DELISTED
Du Pont De Nemours E I
DD
$7K 0.01%
+2,500
New +$170K
INTC icon
321
PUT
Intel
INTC
$478B
$6K ﹤0.01%
50,400
-106,100
-68% -$3.76M
SIMO icon
322
PUT
Silicon Motion
SIMO
$8.96B
$6K ﹤0.01%
+5,500
New +$287K
CHD icon
323
PUT
Church & Dwight Co
CHD
$23.2B
$5K ﹤0.01%
+2,000
New +$98.7K
LUMN icon
324
CALL
Lumen
LUMN
$6.47B
$5K ﹤0.01%
15,400
– –
MRSH
325
PUT
Marsh
MRSH
$87.8B
$5K ﹤0.01%
+15,000
New +$1M
11 12
13
14 15

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.